Cardiol Therapeutics Inc
TSX:CRDL
Cardiol Therapeutics Inc
TSX:CRDL
Price:
1.39
CAD
-0.71%
Market Closed
Market Cap:
CA$155.2m
Balance Sheet
Balance Sheet Decomposition
Cardiol Therapeutics Inc
Cardiol Therapeutics Inc
Balance Sheet Decomposition is not available for
Cardiol Therapeutics Inc
Cardiol Therapeutics Inc
Balance Sheet
Cardiol Therapeutics Inc
Cardiol Therapeutics Inc
Currency: CAD
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
2
|
17
|
7
|
14
|
84
|
59
|
35
|
31
|
|
| Cash Equivalents |
2
|
17
|
7
|
14
|
84
|
59
|
35
|
31
|
|
| Total Receivables |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
7
|
5
|
1
|
3
|
1
|
1
|
1
|
|
| Total Current Assets |
2
|
24
|
14
|
15
|
87
|
61
|
36
|
32
|
|
| PP&E Net |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Intangible Assets |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
3
N/A
|
25
+666%
|
16
-37%
|
16
+3%
|
88
+453%
|
62
-29%
|
37
-41%
|
32
-13%
|
|
| Liabilities | |||||||||
| Accounts Payable |
0
|
2
|
1
|
2
|
5
|
9
|
8
|
7
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
7
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
2
|
1
|
3
|
12
|
10
|
8
|
7
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
2
+551%
|
1
-66%
|
3
+216%
|
12
+344%
|
10
-16%
|
8
-14%
|
7
-16%
|
|
| Equity | |||||||||
| Common Stock |
4
|
37
|
39
|
52
|
143
|
148
|
149
|
179
|
|
| Retained Earnings |
2
|
16
|
30
|
47
|
79
|
111
|
139
|
179
|
|
| Additional Paid In Capital |
0
|
1
|
5
|
9
|
13
|
16
|
19
|
25
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
3
N/A
|
22
+681%
|
15
-34%
|
13
-10%
|
76
+475%
|
52
-32%
|
28
-46%
|
25
-12%
|
|
| Total Liabilities & Equity |
3
N/A
|
25
+666%
|
16
-37%
|
16
+3%
|
88
+453%
|
62
-29%
|
37
-41%
|
32
-13%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
23
|
23
|
26
|
33
|
62
|
64
|
65
|
83
|
|
Switch to:
Switch to:
See Also
Discover More
